Here Are Some Canadian Marijuana Stocks To Watch Mid-August What's next for marijuana stock investors as the sector's recent rise in trading has people talking. Recently there has been an increase in trading that allowed some investors to take profits. Yet in true cannabis fashion, this rise in trading was short-lived. Yet it is moments like this where newfound confidence can be found when looking to invest in legal cannabis. The growth and boom of legal cannabis are still going strong and developing day by ...

David Klein, CEO to retire at the end of the Company's fiscal year Board of Directors expresses continued confidence in the Company's strategic direction and leadership team A comprehensive CEO selection process has been initiated to identify a successor This news release constitutes a "designated news release" for the purposes of Canopy Growth's prospectus supplement dated June 6, 2024 to its short form base shelf prospectus dated June 5, 2024. SMITHS FALLS, ON, Aug. 16, 2024 /PRNewswire/ - Canopy Growth C ...

Canopy Growth Today CGC Canopy Growth $6.88 +0.08 (+1.18%) 52-Week Range $2.76 ▼ $19.20 Price Target $4.53 Add to Watchlist Canopy Growth NASDAQ: CGC is one of the North American players in the cannabis industry. The company's shares have seen massive fluctuations since going public in 2014 under the name Tweed Incorporated. The company's value reached nearly $20 billion in early 2021 but now sits at just $575 million. That current valuation is despite the fact that over the last 12 months, shares are up 69 ...

Core Viewpoint - Tilray Brands has been expanding its operations and improving its financial performance, positioning itself as a more favorable investment compared to Canopy Growth in the cannabis industry [2][4][5]. Group 1: Company Strategies - Tilray Brands has diversified its business by expanding into the alcohol industry, acquiring beverage brands, and becoming a top craft brewer in the U.S. market [4]. - Canopy Growth's strategy is heavily reliant on the potential legalization of cannabis in the U.S., creating a special purpose vehicle, Canopy USA, to hold positions in U.S.-based businesses [3]. Group 2: Financial Performance - Tilray reported an adjusted gross margin of 53% in its alcohol business, compared to 40% in cannabis, and reduced its operating loss to $16.5 million from $90 million year-over-year, with net revenue growing by 25% to $229.9 million [5]. - Canopy Growth's operating loss for the three-month period ended June 30 was CA$29.1 million ($21.2 million), an improvement from CA$54.7 million in the prior-year period, but its revenue declined by 14% to CA$75.8 million [6]. Group 3: Investment Outlook - Despite both companies experiencing significant stock declines over the past three years, Tilray's expansion into alcohol may provide better future results and widen the gap with Canopy Growth [7]. - While Tilray is seen as a better investment option, there are still uncertainties regarding its long-term profitability and growth sustainability [8].

Newsflash: When marijuana is legalized, Americans will buy marijuana legally. Canopy Growth (CGC 1.89%) stock inched 3.2% higher through 10:35 a.m. ET Monday after marijuana news source Marijuana Moment reported on a new positive development for the (legalized) marijuana industry: According to cannabis telehealth platform NuggMD, most Americans now prefer to buy their weed from legal sources. The legal marijuana market There are caveats to this conclusion. As Marijuana Moment describes, NuggMD's survey focu ...

Key Takeaways Canopy Growth Corporation shares dropped Friday after reporting worse-than-expected earnings. Revenues came in 13% lower than a year earlier and net loss widened substantially. Canadian adult-use cannabis sales for the company decreased, offset by an increase in medical cannabis sales Canopy Growth Corporation (CGC) shares dropped Friday after the company's first-quarter fiscal 2025 earnings fell significantly short of expectations. The cannabis producer's revenue of 66.2 million Canadian doll ...

Canopy Growth (NASDAQ:CGC) is among the top Canada-based cannabis producers that investors are watching for clues on how the overall legal marijuana market is performing. Today's decline of more than 8% in CGC stock suggests continued weakness may be forthcoming. The cannabis producer reported revenue for the 2025 fiscal year of $75.8 million, which was down significantly from last year's total of more than $88 million. Even worse, Canopy reported that its net loss ballooned to $127.1 million, or $1.60 per ...

Canopy Growth Corporation. (NASDAQ:CGC) Q1 2025 Earnings Conference Call August 9, 2024 10:00 AM ET Company Participants Tyler Burns - Director, IR David Klein - CEO Judy Hong - CFO Conference Call Participants Aaron Grey - Alliance Global Partners Frederico Gomes - ATB Capital Markets Michael Lavery - Piper Sandler William Kirk - Roth Capital Partners Operator Good morning. My name is Joelle [ph]. I will be your conference operator today. I would like to welcome you to Canopy Growth's First Quarter Fiscal ...

分组1 - Canopy Growth Corporation reported a quarterly loss of $0.37 per share, which was worse than the Zacks Consensus Estimate of a loss of $0.31, and compared to a loss of $0.40 per share a year ago, indicating a surprise of -19.35% [1] - The company posted revenues of $48.39 million for the quarter ended June 2024, missing the Zacks Consensus Estimate by 6.61%, and down from $80.95 million in the same quarter last year [2] - Canopy Growth shares have increased by approximately 35.4% since the beginning of the year, outperforming the S&P 500's gain of 11.5% [3] 分组2 - The current consensus EPS estimate for the upcoming quarter is -$0.27 on revenues of $52.49 million, and for the current fiscal year, it is -$1.07 on revenues of $218.28 million [7] - The Medical - Products industry, to which Canopy Growth belongs, is currently ranked in the top 36% of over 250 Zacks industries, suggesting a favorable outlook for stocks in this sector [8]

About this content About Emily Jarvie Emily began her career as a political journalist for Australian Community Media in Hobart, Tasmania. After she relocated to Toronto, Canada, she reported on business, legal, and scientific developments in the emerging psychedelics sector before joining Proactive in 2022. She brings a strong journalism background with her work featured in newspapers, magazines, and digital publications across Australia, Europe, and North America, including The Examiner, The Advocate, The ...